My name is Colleen Kamrad and I am originally from the United States. I have been with GSK for 10 years and joined as the Vice President and General Manager of Switzerland in January of 2021.
GSK is a global healthcare company headquartered in London, England. Our goal is to unite science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines. We focus on science of the immune system, human genetics, and advanced technologies investing in 4 core therapeutic areas and future opportunities to impact health at scale.
I believe our focus needs to continue to remain on the patients. It is vital that we work with the various players in the healthcare system to ensure patients in Switzerland have rapid and equitable access to innovative medicines.
I am also interested in how we can contribute to having the best healthcare system in Switzerland and one element of that is the need to improve the health data ecosystem.
At GSK we want to positively impact the health of more than 2.5 billion people over the next ten years. By using our science and technology to address health needs, by making our products affordable and available, by being a modern employer and by being a responsible business. Three examples of our ambition with concrete goals:
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2023
Introducing Interpharma
More about the tasks and overriding aims of Interpharma
Contact us
Latest information and media contacts for media representatives